SMA UK and MDUK write to NICE, NHS England and Biogen

02 May 2019

Letters and flyers have been sent urging these three organisations to work strenuously this week so that on May 8th, the NICE committee can endorse an agreement for access to nusinersen (SpinrazaTM) for all with SMA Types 1, 2 and 3. 

Download the flyer here and read each of the letters we sent to:

NICE

NHS England

Biogen